Statens Serum Institut

OrganisationROR

Trials

  • NCT01661985

    Collaborator, Phase 4, Status unknown, 160 people, 10 Aug 2012

  • NCT00252304

    Collaborator, Phase 2/3, Completed, 641 people, 11 Nov 2005

  • NCT00148733

    Collaborator, Phase 2/3, Completed, 2,628 people, 8 Sept 2005

Grants and prizes

  • European Commission

    HORIZON-TMA-MSCA-DN, Effective Delivery of Nucleic Acid Therapeutics via Designed Nanocarriers, 101168881, €301.8k, 2024–2028, 10 Jul 2024

Sources: cordis.europa.eu